The Susan G. Komen Foundation is an awesome organization. It has raised nearly $2 billion dollars in less than 2 decades for breast cancer research. It also has a variety of educational programs. This is an organization that has likely saved hundreds of women’s lives and I think will save thousands of lives through its […]
Trying to understand the Catholic ban on the Komen Charity Read More »
Stem Cell Tourism is a blanket term now used to refer to patients receiving non-FDA approved stem cell treatments either by traveling here within the U.S. or more often outside the U.S. Clinics are sprouting up all over the world offering treatments based on stem cells. The science behind these is often non-existent. Most stem
Stem cell tourism disaster coming: my case for caution Read More »
What will we define as a success for any given stem cell biotech like ViaCyte? In academia, even if we do pre-clinical, translational kind of biomedical sciences, we still do not often think about what it takes to succeed in industry. Even if we very much want our research to make a difference for patients,
There has been a lot of publicity about the reported stem cell treatment of NY Yankees pitcher Bartolo Colon. According to several sources, Colon received his treatment in his native Dominican Republic. Major League Baseball reportedly seems most concerned about this case, at least publicly, because human growth hormone (hGH) might have been used in
Stem cell sports medicine: Bartolo Colon Read More »
I’ve been lecturing on stem cells as a professor here at UC Davis School of Medicine for many years so I can answer common questions such as “What are stem cells?”. The medical students ask many great questions. They are always interested in clinical applications. The goal of today’s article is to help you have
What are stem cells? Definition & what they are used for Read More »
What is the valley of death of science and biotech? For those of us conducting stem cell research, especially human stem cell research, I don’t have to tell you how expensive it is. Even just doing pre-clinical or basic science research costs a fortune. When you start talking about the kind of pre-clinical research specifically
The valley of death: stem cells, biotechs, and money Read More »
Last Fall’s mid-term election brought into office several new Republican Governors who during their campaigns used strong, anti-embryonic stem (ES) cell research rhetoric. For example, then candidate for Governor of Wisconsin, Scott Walker (now the Governor) used some of the strongest language, which was ironic considering that human ES cells were first produced in Wisconsin
New Republican Governors Start Attack On Most Promising Stem Cell Research Read More »
There is a kind of invisible cultural wall between patients such as cancer patients and biomedical scientists like me, but this wall does not have to exist and indeed it is a negative wall as patients, scientists, doctors, agencies, and advocates can achieve far more together than apart. But the wall is surprisingly strong. Last
My Cancer: how I became an advocate too Read More »
Cancer patients and their doctors face daunting challenges at the time of diagnosis. Many crucial questions either cannot be answered or rely upon relatively low-tech methods whose accuracy is far from ideal. For example, how aggressive is this tumor? Has it already spread? After diagnosis and initial treatment, it is critical to monitor patients for
One in a billion: finding stray cancer stem cells Read More »
It has been a rollercoaster few months between the anti-hESC court cases as well as Geron and Advanced Cell Technology (ACT) receiving the OK from the FDA to proceed with initial clinical trials of stem cell treatments. It’s OK to be excited about the clinical trials and I for one am, but we have to
Challenges translating stem cell treatments to patients Read More »